Anapsos reverses interleukin-1β overexpression and behavioral deficits in nbM-lesioned rats

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 19, Issue 5, 1997, Pages 299-309

  Alvarez, X Antón ^a   Franco Maside, Andrés ^a   Zas, Raquel ^a   Sempere, José Miguel ^b   Díaz, Joaquín ^b   Cacabelos, Ramón ^a  

^a Centro de Investigacion Biomedica EuroEspes   (Spain)

^b ASAC Pharma   (Spain)

Author keywords

Anapsos; Brain; Ibotenic acid; Interleukin 1 ; Neuroimmunotrophic activity; Nucleus basalis of Meynert; Passive avoidance learning; Psychomotor activity; Rats

Indexed keywords

IBOTENIC ACID; INTERLEUKIN 1BETA; PLANT EXTRACT; POLYPODIUM LEUCOTOMOS EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DRUG BRAIN LEVEL; IMMUNOMODULATION; NERVE DEGENERATION; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; OLIVARY NUCLEUS; PASSIVE AVOIDANCE; PSYCHOMOTOR ACTIVITY; RAT; TASK PERFORMANCE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; AVOIDANCE LEARNING; BRAIN; EXCITATORY AMINO ACID AGONISTS; FEMALE; GLYCOSIDES; IBOTENIC ACID; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-1; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA INNOMINATA;

EID: 0030883880     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Bigl, V., Arendt, T. Cholinergic neurons on the central nervous system: Morphofunctional aspect. Acta Psychiatr Scan 1991, 366 (Suppl.): 7-13.
2. Gaykema, R.P.A., Gaál, G., Traber, J., Hersh, L.B., Luiten, P.G.M. The basal forebrain cholinergic system: Efferent and afferent connectivity and long-term effects of lesions. Acta Psychiatr Scan 1991, 366 (Suppl.): 14-26.
3. Perry, E.K., Tomlison, B.K., Blessed, G., Bergmann, K., Gibson, P.H., Perry, R.H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 1978, 2: 519-24.
4. Smith, G. Animal model of Alzheimer's disease: Experimental cholinergic denervation. Brain Res Rev 1998, 13: 103-18.
5. Steekler, T., Andrews, J.S., Marten, P., Turner, J.D. Effects of NBM lesions with two neurotoxins on spatial memory and autoshaping. Pharmacol Biochem Behav 1943, 44: 877-84.
6. Alvarez, X.A., Franco, A., Fernández-Novoa, C., Cacabelos, R. Blood levels of histamine, IL-1β and TNF-α in patients with mild to moderate Alzheimer disease. Mol Chem Neuropathol 1996, 29: 237-52.
7. Cacabelos, R., Alvarez, X.A., Fernández-Novoa, L. et al. Brain interleukin-1β in Alzheimer's disease and vascular dementia. Meth Find Exp Clin Pharmacol 1994, 16: 141-51.
8. Cacabelos, R., Barquero, M., Garcia, P., Alvarez, X.A., Varela de Seijas, E. Cerebrospinal fluid interleukin-1β in Alzheimer's disease and neurological disorders. Meth Find Exp Clin Pharmacol 1991, 13: 455-8.
9. Dickson, D.W., Rogers, J. Neuroimmunology of Alzheimer's disease: A conference report. Neurobiol Aging 1992, 13: 793-8.
10. Griffin, W.S.T., Stanley, L.C., Ling, C. et al. Brain interleukin 1 and S100 immunoreactivity are elevated in Down's syndrome and Alzheimer's disease. Proc Natl Acad Sci USA 1989, 86: 7611-5.
11. McGeer, P.L., Itagaki, S., Aklyama, H., McGeer, E.G. Immune system response in Alzheimer's disease. In: Current Communications in Molecular Biology. The Molecular Biology of Alzheimer's Disease. C.E. Finch and P. Davis (Eds.). CHS: New York 1988, 45-50.
12. Wood, P.L. Microglia: A possible cellular target for pharmacological approaches to neurodegenerative disorders. Drug News Perspeet 1994, 7: 138-57.
13. Alvarez, X.A., Franco, A., Fernández-Novoa, L., Cacabelos, R. Effects of anapsos on behavior and brain cytokines in rats. Ann Psychiat 1992, 3: 329-41.
14. Breder, C.D., Dinarello, C.A., Saper, C.B. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 1988, 240: 321-4.
15. Lechan, R.M., Toni, R., Clark, B.D. et al. Immunoreactive interleukin-1β in the rat forebrain. Brain Res 1990, 514: 135-40.
16. Alvarez, X.A., Cacabelos, R. Influence of growth hormone (GH) and GH-releasing factor on locomotor activity in rats. Peptides 1993, 14: 707-12.
17. Yabuuchi, K., Minami, M., Katsumata, S., Satoh, M. Localization of type 1 interleukin-1 receptor mRNAs in the brain. Mol Brain Res 1994, 27: 27-36.
18. Rothwell, N.J., Relton, J.K. Involvement of cytokines in acute neurodegeneration in the CNS. Neurosci Behav Rev 1993, 17: 217-27.
19. Cacabelos, R., Alvarez, X.A., Franco-Maside, A., Fernández-Novoa, L., Caamaño, J. Effect of CDP-choline on cognition and immune function in Alzheimer's disease and multi-infaret dementia. Ann NY Acad Sci 1993, 695: 321-3.
20. Blume, A.J., Vitek. M.P. Focusing on ILI-production of β-amyloid precursor protein synthesis as an early event in Alzheimer's disease. Neurobiol Aging 1989, 10: 406-8.
21. Gray, C.W., Patel, A.J. Regulation of β-amyloid precursor protein isoform mRNAs by transforming growth factor-β1 and interleukin-1β in astrocytes. Mol Brain Res 1993, 19: 251-6.
22. Griffin, W.S.T., Sheng, J.G., Gentleman, S.M., Graham, D.I., Mrak, R.E., Roberts, G.W. Microglial interleukin-1α expression in human head injury: Correlations with neuronal and neuritic β-amyloid precursor protein expression. Neurosci Lett 1994, 176: 133-6.
23. Toulmond, S., Rothwell, N.J. Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Brain Res 1995, 671: 261-6.
24. Horvath, A., Alvarado, F., Szöcs, J., De Alvarado, Z.N., Padilla. G. Metabolic effects of Calagualine, an antitumoral saponine of Polypodium Leucotomos. Nature 1967, 214: 1256-8.
25. Jiménez, D., Naranjo, R., Doblaré, E., Muñoz, C., Vargas, J.F. Anapsos, an antipsoriatic drug, in atopic dermatitis. Allergol Immunopathol 1987, 15: 185-9.
26. Padilla, H.C., Lainez, H., Pacheco, J.A. A new agent (hydrophilic fraction of Polypodium Leucolamos) for management of psoriasis. Int J Dermatol 1974, 13: 276-82.
27. Tuominen, M., Bohlin, L, Lindhom, L.-O., Rolfsen, W. Enhancing effect of Calaguala on the prevention of rejection on skin transplants in mice. Phytotherapy Res 1991, 5: 234-6.
28. Vargas, J., Muñoz, C., Osorio, C., Garcia-Olivares, E. Anapsos, an antipsoriatic drug which increases the proportion of suppressor cells in human peripheral blood. Ann Immunol 1983, 134: 393-400.
29. Alvarez, X.A., Zas, R., Lagares, R. et al. Neuroimmunomodulatory and neurotrophic activity of anapsos: Studies with laboratory animals. Ann Psychiat 1995, 5: 267-80.
30. Paxinos, G., Watson, C. The Rat Brain in Coordinates. Academic Press: Sydney 1982.
31. Araujo, D.M., Cotman, C.W. β-amyloid stimulates grial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease. Brain Res 1992, 569: 141-5.
32. Itakura, T., Umemoto, M., Kamei, I. et al. Autotransplantation of peripheral cholinergic neurons into the brains of Alzhiemer model rats. Acta Neurochir 1992, 115: 127-32.
33. Alvarez., X.A., Franco, A., Fernández-Novoa, L., Cacabelos, R. Effects of betahistine on locomotor activity and passive avoidance behavior in rats. Agents Actions 1993, 38: C63-5.
34. Alvarez, X.A., Franco, A., Fernández-Novoa, L., Cacabelos, R. Effects of S 9977-2 on psychomotor activity, learning and brain interleukin-1β levels in rats. Meth Find Exp Clin Pharmacol 1993, 15: 587-95.
35. Bartus, R.T., Flicker, C, Dean, R.L., Pontecorvo, M., Figueiredo, J.C., Fisher, S.K. Selective memory loss following nucleus basalis lesions: Long-term behavioral recovery despite persistent cholinergic deficits. Pharmacol Biochem Bchav 1985, 23: 125-35.
36. Page, K.J., Everid, B.J., Robbins, T.W., Marston, H.M., Wilkinson, L.S. Dissociable effects on spatial maze and passive avoidance acquisition and retention following AMPA- and ibotenic acid-induced excitotoxic lesions of the basal forebrain in rats: Differential dependence on cholinergic neuronal loss. Neuroscience 1991, 43: 457-72.
37. Santucci, A.C., Kanof, P.D., Haroutunian, V. Effect of physostigmine on memory consolidation and retrieval processes in intact and nucleus basalis-lesioned rats. Psychopharmacology 1989, 99: 70-4.
38. Crestani, F., Scguy, F., Danizer, R. Behavioural effects of peripherally injected interleukin-1: Role of prostaglandins. Brain Res 1991, 542: 330-5.
39. Del Cerro, S., Borrell, J. Interleukin-1 affects the behavioral despair response in rats in an indirect mechanism which requires endogenous CRF. Brain Res 1990, 528: 1624.
40. Brenneman, D.E., Schultzberg, M., Bartfai, T., Gozes, I. Cytokine regulation of neuronal survival. J Neurochem 1992, 58: 454-60.
41. Steward, O., Tomasulo, R., Torre, E., Trimmer, P. Reorganization of neural connections following CNS injury: Is synaptic reorganization initiated by the changes in neuronal activity which occur following injury? Brain Dysfunct 1992, 5: 27-49.
42. Strijbos, P.J.L.M., Rothwell, N.J. Interleukin-1β attenuates excitatory amino acid-induced neurodegeneration in vitro: Involvement of nerve growth factor. Neurosci 1995, 15: 3468-74.
43. Anezaki, T., Yanagisawa, K., Takahashi, H. et al. Remote astrocytic response of prefrontal cortex is caused by the lesions in the nucleus basalis of Meynert, but not in the ventral tegmental area. Brain Res 1992, 574: 63-9.
44. Wallace, W.C., Bragin, V., Robakis, N.K. et al. Increased biosynthesis of Alzheimer amyloid precursor protein in the cerebral cortex of rats with lesions of the nucleus basalis of Meynert. Brain Res Mol Brain Res 1991, 10: 173-8.
45. Alvarez, X.A., Zas, R., Lagares. R. et al. Anapsos: New therapeutic strategies for neurodegeneration and brain aging with neuroimmunotrophic factors. In: Alzheimer Disease: From Molecular Biology to Therapy. Becker, R., Giacobini, E. (Eds.). Birkhäuser: Boston 1996, 367-72.